Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL‐AF registry
Journal of Diabetes · 2024
DOI: 10.1111/1753-0407.13519 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Diabetes, 2024. Verfasst von Rungroj Krittayaphong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Atrial Fibrillation, Obesity, Registries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health System Research Institute, Heart Association of Thailand.
Abstract (Originalsprache)
Background
The primary objective was to determine the influence of obesity and associated metabolic status on clinical outcomes of Asian patients with atrial fibrillation (AF).
Methods
This study was based on a prospective multicenter of patients with nonvalvular AF. Patients were classified as obese and nonobese and being metabolic unhealthy was defined as having at least one of the three cardiovascular risk factors including dyslipidemia, hypertension, or diabetes mellitus. Outcomes were a primary composite outcome of all‐cause death, ischemic stroke/systemic embolism (SSE), acute myocardial infarction (MI), and heart failure (HF), as well as the individual end points.
Results
There were a total of 3141 enrolled patients (mean age 67.4 ± 11.1 years; 41.0% female), of whom 1566 (49.9%) were obese and 2564 (81.6%) were metabolic unhealthy. During a mean follow‐up of 32.2 ± 8.3 months, the incidence rate of the composite outcome, all‐cause death, SSE, MI, and HF were 7.21 (6.63–7.82), 3.86 (3.45–4.30), 1.48 (1.23–1.77), 0.47 (0.33–0.64), and 2.84 (2.48–3.23) per 100 person‐years, respectively. Metabolic unhealthy nonobese subjects were at higher risk of the composite outcomes than metabolic unhealthy obese subjects with hazard ratio (HR) 1.39, 95% confidence interval (CI) 1.17–1.66, p < .001. Metabolic unhealthy obese subjects tend to have an increased risk of the composite outcomes compared to those metabolic healthy obese (HR 1.36, 95% CI 0.91–2.02, p = .133). Metabolic healthy obese subjects were not associated with increased risk.
Conclusions
Metabolic unhealthy obese subjects were associated with an increased risk of adverse outcomes in AF patients, whereas metabolically healthy obesity was not associated with an increased risk. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Lampang Hospital, Lampang, Thailand.
- Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
- Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID-Profile: Rungroj Krittayaphong
Förderung
- Health System Research Institute
- Heart Association of Thailand
Zitieren
APA
Krittayaphong, R., Boonyapiphat, T., Winijkul, A., & Lip, G. Y. H. (2024). Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL‐AF registry. Journal of Diabetes. https://doi.org/10.1111/1753-0407.13519
Vancouver
Krittayaphong R, Boonyapiphat T, Winijkul A, Lip GYH. Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL‐AF registry. Journal of Diabetes. 2024. doi:10.1111/1753-0407.13519
BibTeX
@article{Krittayaphong2024,
author = {Krittayaphong, Rungroj and Boonyapiphat, Thanita and Winijkul, Arjbordin and Lip, Gregory Y H},
title = {Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL‐AF registry},
journal = {Journal of Diabetes},
year = {2024},
doi = {10.1111/1753-0407.13519}
}
EUVIMED